Jonathan Birchall - 08 Nov 2021 Form 3 Insider Report for PhaseBio Pharmaceuticals Inc

Role: Chief Commercial Officer
Signature: /s/ John P. Sharp, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 08 Nov 2021
Net transactions value: $0
Form type: 3
Filing time: 09 Nov 2021, 19:45:00 UTC
Next filing: 28 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney